Health Care Financing Administration 7500 Security Blvd., Baltimore, MD 21244-1850

R -- HEMODIALYSIS CLINICAL TRIAL COST EFFECTIVENESS STUDY SOL HCFA-97-012/PK POC Paula Kolick, Contract Specialist, 410-786-5165. The Health Care Financing Administration (HCFA) has a requirement for a contractor to collect, organize and analyze the economic data needed to perform a cost effectiveness analysis of the HEMOdialysis (HEMO) Clinical Trial. The HEMO trial is currently enrolling patients with end-stage renal disease treated with in-center hemodialysis to compare the mortality and morbidity outcomes of high flux versus low flux dialysis membranes and high Kt/V versus standard Kt/V, singly and in combination. The prospective contractor to be recruited through this RFP will work with the HEMO trial's clinical and data centers funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) which are responsible for all clinical data collection, database maintenance and outcome analyses. The Statement of Work for the HCFA RFP contains four areas of work: 1) pretest and finalize the data collection protocol and instruments, 2) collect on-site data on the cost of dialysis in the approximately 70 dialysis facilities participating in the HEMO trial, 3) analyze the economic data on dialysis costs and enrollees' other direct medical costs using Medicare administrative and billing records, and 4) conduct a cost effectiveness analysis of the HEMO study. The Government anticipates a 42-month period of performance. Requests for the RFP must be in writing and marked ATTN; RFP-HCFA-97-012/PK. Telephone request will not be honored. Requests for the solicitation document must be in writing and received within fifteen (15) calendar days from date of publication of this snyopsis. (0099)

Loren Data Corp. http://www.ld.com (SYN# 0079 19970411\R-0006.SOL)